SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
NCT06937281
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Metastases
Interventions
RADIATION:
SABR
Sponsor
British Columbia Cancer Agency